I. Introduction
Osteoporosis is an age-related, chronic, metabolic disease [1] clinically featured by the degeneration of bone microarchitecture, thinning of bone thickness, and reduction of bone mass [2], which may finally develop to bone morphology change or even evolves to fracture when the bone fragility remarkably increases [3]. Although the onset of osteoporosis is not easily perceived, and no acute symptom can be observed, the life quality of patient would be significantly decreased due to the miss of best time for treatment and then the progress into severe osteoporosis [4]. The clinically gold standard of osteoporosis diagnosis is the measurement of bone mineral density (BMD) using dual-energy X-ray absorptiometry (DXA) [5], whereas BMD as inorganic composition only accounts for approximately 60%∼70% of bone strength [6]. Nevertheless, several other factors has been reported to be important determinants of bone strength, such as morphology, microstructure, and other contents in bone, which cannot be measured by DXA [6]. As two mature tools for clinical assessment of bone geometry and microstructure, the applications of computed tomography (CT) and magnetic resonance imaging (MRI) are limited [7], considering the relatively high costs, long time of inspection, ionizing radiation (CT), and poor mobility.